These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15912821)

  • 1. [Combining effectiveness and tolerance].
    Krankenpfl J; 2005; 43(1-3):26-7. PubMed ID: 15912821
    [No Abstract]   [Full Text] [Related]  

  • 2. Aripiprazole: novelty, adherence and understatement.
    Fear C
    Int J Neuropsychopharmacol; 2005 Mar; 8(1):131. PubMed ID: 15469664
    [No Abstract]   [Full Text] [Related]  

  • 3. The patient with schizophrenia taking aripiprazole: case report.
    Uzun S; Kozumplik O; Mimica N; Folnegović-Smalc V
    Psychiatr Danub; 2005 Dec; 17(3-4):234-5. PubMed ID: 16392433
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aripiprazole in the treatment of schizophrenia].
    Bridler R
    Praxis (Bern 1994); 2005 Jun; 94(23):975-7. PubMed ID: 16001540
    [No Abstract]   [Full Text] [Related]  

  • 5. ["Higher outcomes"--optimizing therapy of schizophrenia].
    Rüther E
    Krankenpfl J; 2004; 42(5-6):151. PubMed ID: 15527215
    [No Abstract]   [Full Text] [Related]  

  • 6. [CUtLASS 1 - Increasing disillusion about 2nd generation neuroleptics].
    Steinert T
    Psychiatr Prax; 2007 Jul; 34(5):255-7. PubMed ID: 17607643
    [No Abstract]   [Full Text] [Related]  

  • 7. Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.
    Kane JM
    J Clin Psychiatry; 2003; 64 Suppl 19():3-5. PubMed ID: 14728083
    [No Abstract]   [Full Text] [Related]  

  • 8. Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia.
    Gründer G; Kungel M; Ebrecht M; Göröcs T; Modell S
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S21-5. PubMed ID: 16508892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents.
    Prescrire Int; 2009 Dec; 18(104):251. PubMed ID: 20025091
    [No Abstract]   [Full Text] [Related]  

  • 10. Extrapyramidal side effects associated with aripiprazole administration in a schizophrenic patient.
    Hung GC; Chen YY
    Pharmacopsychiatry; 2007 Mar; 40(2):83-4. PubMed ID: 17447180
    [No Abstract]   [Full Text] [Related]  

  • 11. The stable patient with schizophrenia--from antipsychotic effectiveness to adherence.
    Thomas P
    Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S115-22. PubMed ID: 17336766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease].
    Naber D; Lambert M; Karow A
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S230-2. PubMed ID: 15586315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole in schizophrenia: consensus guidelines.
    Travis MJ; Burns T; Dursun S; Fahy T; Frangou S; Gray R; Haddad PM; Hunter R; Taylor DM; Young AH
    Int J Clin Pract; 2005 Apr; 59(4):485-95. PubMed ID: 15853869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Compliance].
    Vandel P
    Encephale; 2007 Jun; 33 Pt 3():S399-401. PubMed ID: 19101359
    [No Abstract]   [Full Text] [Related]  

  • 16. [Expectation and development of atypical antipsychotic drugs].
    Ther Umsch; 2004 Sep; 61(9):1 p preceding 539. PubMed ID: 15493111
    [No Abstract]   [Full Text] [Related]  

  • 17. Aripiprazole in chronic schizophrenia: experiences in daily practice.
    Fernald DS; van Dellen RT; Hovens JE; Loonen AJ
    Acta Psychiatr Scand; 2006 Oct; 114(4):294; author reply 294. PubMed ID: 16968370
    [No Abstract]   [Full Text] [Related]  

  • 18. Aripiprazole (Abilify) for schizophrenia.
    Med Lett Drugs Ther; 2003 Feb; 45(1150):15-6. PubMed ID: 12592215
    [No Abstract]   [Full Text] [Related]  

  • 19. [Exercising caution in choice of psychotropic drugs. Avoid drug-induced weight gain].
    MMW Fortschr Med; 2002 May; Suppl 2():89. PubMed ID: 12070872
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study.
    Kim SH; Ivanova O; Abbasi FA; Lamendola CA; Reaven GM; Glick ID
    J Clin Psychopharmacol; 2007 Aug; 27(4):365-8. PubMed ID: 17632220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.